Tag: Human Papillomavirus (HPV)
Cervical Cancer Screening Rates Dropped During Stay-at-Home Order
Cervical cytology screening rates per 100 person-months decreased 78 percent among women aged 21 to 29 years
Timing, Intensity of Oral Sex Are Risk Factors for HPV-OPC
Increased odds of human papillomavirus oropharyngeal cancer seen for younger age at first oral sex, oral sex intensity
Interventions to Increase HPV Vaccine Coverage Cost-Effective
Interventions could avert 3,000 to 14,000 future HPV cancers scaling to the U.S. population
HPV Vaccine Generally Well Tolerated in Males
Disproportionate reports found for some adverse events, including syncope, with reporting odds ratio of 2.85
HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30
HPV Vaccination Rates Increasing Among 15-Year-Olds
Proportion of one- or two-dose HPV vaccination increased from 2011 to 2017; still falling short of goals
Adolescent Vaccinations Decreased During COVID-19 Pandemic
Decrease could offset increased coverage noted from 2018 to 2019 in HPV vaccination, MenACWY
Teen HPV Vaccination Rates Suboptimal
Half of parents of unvaccinated teens have no intention to initiate the vaccine series
ACS Issues Updated Guideline for Cervical Cancer Screening
Screening, preferably with primary HPV testing, should start at age 25 and continue through age 65
American Cancer Society Updates HPV Vaccination Guidelines
Vaccination should be routinely offered at age 9 to 12 years; catch-up vaccination recommended through age 26
